Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference
Viking Among Notable Gainers as Pfizer Raises Deal Prospects
We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate
Terns Pharma Analyst Ratings
$TERN Stock Is up 15% Today. Here's What We See in Our Data.
SA Asks: What's the Best Weight-loss Drug Stock Right Now?
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $14
Pfizer (PFE.US) facing setbacks in research sparks acquisition speculation, stocks of the new weight loss drug rising sharply.
Pfizer (PFE.US) has stopped the development of the highly anticipated oral weight loss drug Danuglipron. Investors are betting that this setback may prompt Pfizer to seek acquisition trades, leading to a rise in the stock prices of several biotechnology companies developing weight loss drugs on Monday.
Viking, Structure, Metsera on a Tear as Pfizer Drops Obesity Pill
Terns Pharmaceuticals Management to Meet With Oppenheimer
Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN)
Express News | Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Insiders' US$5.17m Investments In Red Following Terns Pharmaceuticals' US$52m Dip In Market Value
TD Cowen Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating
All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy
Oppenheimer Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $20
Terns Pharmaceuticals Reports 2024 Progress and Outlook
JMP Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $20
Terns Pharmaceuticals: Promising Investment With Strong Financials and Strategic Developments